Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
Service Availability is Expected in January 2021MOUNTAIN VIEW, CA and REHOVOT, ISRAEL, Dec. 14, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, and Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 ...
Presentation on Tuesday December 15th at 11:00am ESTLOS ANGELES, CA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that it will be presenting at the 13th annual LD Micro Main Event investor conference on Tuesday, December 15, 2020 at 11:00 AM EST ...
To Indicate Interest in a Personal AditxtScore™ for COVID-19, Visit AditxtScore.com MOUNTAIN VIEW, CA, Nov. 30, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that physician and media personality Dr. Drew Pinsky, a senior advisor to Aditxt, and Aditxt CEO Amr...
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Voorhies has Extensive Business and Industry Experience in Diagnostics & Monitoring Mountain View, CA, Nov. 20, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that it has appointed Anthony Voorhies as Head of Business Development for AditxtScore™. Mr. Voor...
Upcoming Vaccines Increase the Need for Ongoing Monitoring of Presence and Durability of ImmunityMountain View, CA , Nov. 19, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that its AditxtScore™laboratory operations for immune monitoring has secured CLIA ce...
Mountain View, CA, Nov. 13, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today provided a business update in conjunction with the filing of its Form 10-Q with the Securities and Exchange Commission. Amro Albanna, Co-Founder and CEO of Aditxt, commented, “It’s been an ex...
First AditxtEngage™Event with Amro Albanna, CEO, to be held on Tuesday, October 6that 4:30pm ET Mountain View, CA, Oct. 02, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced the launch of AditxtEngage™, a continuing series of investor opportunities to engage ...